US Radiation Dose Market is expected to grow yearly by 50%

The predictions about the U.S. Radiation Dose Management Market are promising according to Micro Market Monitor: the market, existing of radiation dose management software and radiation dose management services, is expected to grow until 2020 with a compound annual growth rate of nearly 50%, or from USD 33.7 million in 2015 to USD 205.6 million by 2020. QAELUM N.V is stated in the list of prominent players in the U.S Radiation Dose Management Market.

U.S. regulations focus on patient safety and improvement of the quality of healthcare

The U.S Radiation Dose Management Market will expand tremendously in the future and follows in this way the same trend as the European market. Accreditation, certification and clinical audits are getting more demanding driven by the increasing radiation exposure risks. Also on governmental level regulations are being implemented, which mandate dose monitoring, tracking, and maintenance of patient dose records. From February 2018 onwards, clinical audits will be obliged for every European radiology department, but initiatives are also being taken by the U.S government. Since January 2016 for example, healthcare providers are required to ensure that their CT scanners are compliant with the radiation dose optimization standard – the XR-29/MITA Smart Dose - in order to avoid a cut in Medicare reimbursement. Accordingly, dose management solutions are needed to monitor, optimize and reduce radiation dose during diagnostic imaging procedures, with recurring keywords “patient safety” and “improvement of the quality of healthcare”.

QAELUM is ready to enter the U.S. market

In this report, published last April, QAELUM is mentioned as prominent player in the Radiation Dose Management Market, next to the big players. As there are obviously many opportunities for QAELUM in the U.S. together with the FDA clearance we’ve obtained, opening a U.S. office was a logical next milestone. Last week, our CEO Jurgen and VP Global Sales Luc officially opened a QAELUM office in Manhattan, New York to kick off US business! We will start the expansion at the East-coast of the US because it holds a high density of larger hospitals, and it gives easy access to major Canadian cities for continued prospection. QAELUM is already active in 16 European countries and in the Middle-East, but if the predictions of the Micro Market Monitor report are correct, our software solutions could also serve many U.S. hospitals in the coming years.